Alejandro Llanos-Cuentas Selected Research

Mucocutaneous Leishmaniasis

4/2011	Polymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis.
6/2007	Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Llanos-Cuentas Research Topics

Disease

13	Leishmaniasis 01/2022 - 03/2006
13	Cutaneous Leishmaniasis 01/2022 - 02/2005
11	Infections 01/2021 - 09/2007
10	Malaria 05/2022 - 10/2006
8	Vivax Malaria 05/2022 - 12/2010
4	Glucosephosphate Dehydrogenase Deficiency 05/2022 - 01/2015
3	Parasitemia 01/2019 - 09/2007
2	Hemolysis 05/2022 - 01/2015
2	Mucocutaneous Leishmaniasis 04/2011 - 06/2007
1	Vomiting 01/2022
1	COVID-19 01/2021
1	Intestinal helminthiasis 05/2020
1	Strongyloidiasis 05/2020
1	Helminthiasis (Helminthiases) 01/2018
1	Coinfection 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Reinfection 10/2015
1	Ulcer 01/2015
1	Body Weight (Weight, Body) 10/2013
1	Visceral Leishmaniasis (Kala Azar) 10/2013
1	Wounds and Injuries (Trauma) 01/2012
1	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2007

Drug/Important Bio-Agent (IBA)

8	tafenoquineIBA 05/2022 - 03/2014
4	Pharmaceutical PreparationsIBA 03/2016 - 10/2006
3	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 05/2022 - 01/2015
3	Meglumine AntimoniateIBA 01/2022 - 02/2005
3	Primaquine FDA Link 01/2019 - 02/2016
3	Kinetoplast DNA (kDNA)IBA 01/2016 - 04/2011
3	DNA (Deoxyribonucleic Acid)IBA 06/2012 - 09/2007
3	AntimonyIBA 01/2012 - 07/2009
2	EnzymesIBA 01/2022 - 03/2006
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	VaccinesIBA 01/2021 - 10/2010
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2021
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2019 - 01/2016
2	Antimalarials (Antimalarial Agents)IBA 01/2018 - 06/2016
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2016
2	Chloroquine (Aralen)FDA LinkGeneric 03/2016 - 03/2014
2	AntibodiesIBA 01/2015 - 01/2011
2	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2013 - 06/2007
2	Imiquimod (Aldara)FDA LinkGeneric 07/2009 - 06/2007
1	miltefosine (Impavido)IBA 01/2022
1	IsoenzymesIBA 04/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021
1	InsecticidesIBA 01/2021
1	AgarIBA 05/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	DSM265IBA 01/2018
1	Dihydroorotate DehydrogenaseIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	GoldIBA 12/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	AntigensIBA 10/2015
1	8-aminoquinolineIBA 01/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013
1	Biological ProductsIBA 12/2010
1	PolyproteinsIBA 10/2010
1	Antimony Sodium Gluconate (Sodium, Stibogluconate)IBA 10/2010
1	Interleukin-10 (Interleukin 10)IBA 01/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2010
1	CXCR3 ReceptorsIBA 01/2010
1	Chemokine ReceptorsIBA 01/2010
1	Chemokine CXCL10IBA 01/2010
1	Mefloquine (Lariam)FDA LinkGeneric 10/2007
1	artenimol (dihydroartemisinin)IBA 10/2007
1	piperaquineIBA 10/2007
1	ArtesunateIBA 10/2007
1	Immunologic Factors (Immunomodulators)IBA 10/2006
1	Pentamidine (NebuPent)FDA LinkGeneric 02/2005

Therapy/Procedure

8	Therapeutics 01/2021 - 06/2007
2	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2013
2	Secondary Prevention 01/2019 - 03/2014
2	Drug Therapy (Chemotherapy) 01/2016 - 06/2007
1	Mass Drug Administration 05/2022
1	Oral Medicine 01/2018
1	Lasers (Laser) 01/2012
1	Injections 10/2010